K Rossing, P Jacobsen, L Pietraszek, HH … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 20 patients (17 men and 3 women) with
type 2 diabetes along with hypertension and nephropathy were enrolled in this
double-blind, randomized, two-period, crossover trial of 8 weeks of ... Cited by 170 - Related articles - BL Direct - All 6 versions
- ►asnjournals.org P Jacobsen, S Andersen, BR Jensen, HH … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol Albuminuria and hypertension are predictors of poor renal and cardiovascular
outcome in patients with diabetes (1,2 ). Antihypertensive treatment, especially
ACE-I, has been shown to reduce albuminuria, to diminish loss of kidney ... Cited by 154 - Related articles - BL Direct - All 7 versions
P Jacobsen, S Andersen, K Rossing, BR … - Kidney international, 2003 - nature.com Albuminuria and hypertension are predictors of poor renal and cardiovascular
outcome in diabetic patients. We tested whether dual blockade of the
renin-angiotensin system (RAS) with both an angiotensin-converting enzyme ... Cited by 194 - Related articles - BL Direct - All 4 versions
FD Care - orthopedics.medscape.com Despite the proven benefit of RAS blockade by either ACEIs or ARBs, clinical
studies to date have found that such treatment slows but does not completely
arrest the progression of renal disease toward end-stage renal disease. ... Related articles - All 4 versions
- ►oxfordjournals.org P Jacobsen, S Andersen, K Rossing, BV … - Nephrology Dialysis Transplantation, 2002 - ERA-EDTA Results. Addition of 300 mg Irbesartan to the patients' usual antihypertensive
therapy induced a mean reduction in albuminuria of 37% (95% CI 20–49,
P<0.001); from 1574 mg/24 h (95% CI 1162–2132) to 996 mg/24 h (95% CI ... Cited by 117 - Related articles - BL Direct - All 4 versions
K Rossing, PK Christensen, BR Jensen, HH … - Diabetes Care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We performed a randomized double-blind crossover
study of 2 months treatment with candesartan cilexetil 8 mg once daily and
placebo in addition to previous antihypertensive treatment. We included 18 ... Cited by 183 - Related articles - BL Direct - All 5 versions
GD Laverman, G Navis, RH Henning, PE De … - Kidney international, 2002 - nature.com To this purpose, lisinopril and losartan were studied in 9 nondiabetic renal
patients with median proteinuria 4.5 g/day (95% CI, 3.5, 6.4), creatinine
clearance of 80 mL/min (95% CI, 66, 96), and mean arterial pressure (MAP) ... Cited by 126 - Related articles - BL Direct - All 5 versions
CE Mogensen, S Neldam, I Tikkanen, S Oren, … - British medical journal, 2000 - bmj.com The role of inhibition of the renin-angiotensin system in preventing
microvascular complications, particularly nephropathy, in patients with daibetes
has been clearly shown. 1-3 In many people with evidence of diabetic renal ... Cited by 776 - Related articles - BL Direct - All 15 versions
R Agarwal - Kidney international, 2001 - nature.com Sixteen patients with proteinuric moderately advanced chronic renal failure
completed a two-period, crossover, randomized controlled trial. Each period was
one month with a two-week washout between periods. In one period, patients ... Cited by 121 - Related articles - BL Direct - All 4 versions
K Rossing, PK Christensen, BV Hansen, B … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A total of 23 hypertensive patients with type 2
diabetes and nephropathy were enrolled in this double-blind randomized
cross-over trial with four treatment periods, each lasting 2 months. Each ... Cited by 52 - Related articles - BL Direct - All 5 versions
